Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06882356 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Glaucoma and Retinopathy Screening Study

Study acronym: GRaSS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 5 to 7
    • Eligibility criteria shortened, about 3 words
    v6
  2. Study sites: 4 to 5v5
  3. Start date changed from estimate of Jul 14, 2025 to Jul 16, 2025
    • Site details revised at 1 of 4 sites
    v4
  4. Study sites: 1 to 4
    • Start date: Jun 30, 2025 to Jul 14, 2025
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 15, 2025 to Jun 30, 2025
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Trial Details
NCT Number NCT06882356
Lead Sponsor Massachusetts Eye and Ear Infirmary
Collaborators: Centers for Disease Control and Prevention
Conditions
(from sponsor)		 Glaucoma
Related terms Glaucoma
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov